USAGE OF PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS AND ANTI-CD20 AGENTS TO TREAT HEMATOLOGIC CANCERS

• 收藏
• 分享

专利权人:

BIOCRYST PHARMACEUTICALS; INC.

发明人:

BANTIA, SHANTA,BREITFELD, PHILIP,BABU, YARLAGADDA, S

申请号：

GEAP2008012864

公开号：

GEP20156288B

申请日:

2008.12.10

申请国别(地区):

GE

年份:

2015

代理人:

摘要：

Present invention relates to hematologic cancers treatment including application of purine nucleoside phosphorylase (PNP) inhibitor combina¬tion with alkylating agent and anti-CD20 agent. Invention also relates to compositions containing said combination, and kit additionally including system supplying such combination.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/